![Gonzalo Santillan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenienza dei contatti di primo grado di Gonzalo Santillan
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Keclon SA
![]() Keclon SA BiotechnologyHealth Technology Keclon SA engages in the development and generation of synthetic enzymes. Its technology platform allows to rapidly generating new and improved enzymes that can significantly reduce production costs using genetic engineering, synthetic biology and directed evolution tools. The company was founded by Hugo Menzella, Leandro Vetcher, Sebastian Bernales and Salvador Peiru, Rodolfo Cabrera in December 2011, and is headquartered in Rosario, Argentina.
5
| Holding Company | Biotechnology | 5 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Gonzalo Santillan tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Northwestern University
![]() Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Doctorate Degree | |
Ventria Bioscience, Inc.
![]() Ventria Bioscience, Inc. BiotechnologyHealth Technology Ventria Bioscience, Inc. operates as a biopharmaceutical company. It offers Express Tec., a plant based recombinant protein supplement. The firm also offers controlling zoonotic disease and also provides access to its platform technology through contract manufacturing services. The company was founded by Raymond L. Rodriguez, Peter Matlock and William J. Rutter in 1993 and is headquartered in Fort Collins, CO. | Biotechnology | Founder | |
Grupo Bios SA | Founder | ||
Alta Ventures México SC
![]() Alta Ventures México SC Investment ManagersFinance Alta Ventures México SC (Alta Ventures) is an independent venture capital firm founded in 2010 by Paul Ahlstrom. The firm is headquartered in Nuevo Leon, Mexico. | Investment Managers | Private Equity Investor | |
Andes Biotechnologies SA
![]() Andes Biotechnologies SA BiotechnologyHealth Technology Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile. | Biotechnology | Founder | |
Fundacion Endeavor Argentina
![]() Fundacion Endeavor Argentina Miscellaneous Commercial ServicesCommercial Services Part of Endeavor Global, Inc., Fundacion Endeavor Argentina is an Argentinean company that provides business support services. The company is based in Buenos Aires, Argentina. The company was founded in 1998 by Lisandro Bril, Eduardo Sergio Elsztain, Woods White Staton, Andrés Freire, Saúl Zang, Carlos Adamo, Maria Eugenia Estenssoro, Oscar Toppelberg. Maria Julia Bearzi has been the CEO of the company since 2016. | Miscellaneous Commercial Services | Founder | |
AUSTRAL Biologicals | Founder | ||
Chilean Academy of Science | Corporate Officer/Principal | ||
Holdinvest Gestión SA
![]() Holdinvest Gestión SA Investment ManagersFinance Holdinvest SA operates as a venture capital investment firm. It specializes in technology investments. The firm offers venture capital advisory to investors and entrepreneurs. The company was founded by Lisandro Bril and is headquartered in Argentina. | Investment Managers | Founder | |
Unleash Immuno Oncolytics, Inc.
![]() Unleash Immuno Oncolytics, Inc. BiotechnologyHealth Technology Unleash Immuno Oncolytics, Inc. develops oncolytic virus immunotherapy products to treat cancer. Its product is UIO-512. the company is headquartered in Saint Louis, MO. | Biotechnology | Director/Board Member | |
Axia Ventures | Investment Managers | Private Equity Investor | |
Algenis SpA
![]() Algenis SpA BiotechnologyHealth Technology Algenis SpA conducts research on small molecules derived from microalgae. It produces, formulation and clinical developments bioactive molecules produced by marine microalgae with medical application as muscle relaxant and analgesic, as well as for the treatment of neurological diseases. The company also conducted academic clinical research and published their work in several peer-reviewed journals. Algenis was founded in 2002 and is headquartered in Santiago, Chile. | Biotechnology | Director/Board Member | |
Andes Biotechnologies Global, Inc.
![]() Andes Biotechnologies Global, Inc. BiotechnologyHealth Technology Andes Biotechnologies Global, Inc. provides healthcare services. The company was founded in 2017 and is headquartered in Burlingame, CA. | Biotechnology | Chief Executive Officer | |
Fundación Ciencia Para La Vida | Founder |
Statistiche
Distribuzione geografica
Stati Uniti | 8 |
Cile | 6 |
Argentina | 4 |
Messico | 2 |
Settori
Health Technology | 8 |
Finance | 4 |
Consumer Services | 2 |
Commercial Services | 2 |
Posizioni
Director/Board Member | 11 |
Founder | 8 |
Chief Executive Officer | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Chairman | 2 |
Contatti più connessi
- Borsa valori
- Insiders
- Gonzalo Santillan
- Connessioni Società